SCHEMBL7684920

SCHEMBL7684920

CC[C@H]1CCNc2cc(O)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.42
PGR P06401 1/20 0.41
MEN1 O00255 2/20 0.41
GLA P06280 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
NR1I2 O75469 1/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648117 1.00 AR (0.42) ARPGRMEN1GLAKMT2A
SCHEMBL14975544 0.91 MEN1 (0.39) ARPGRMEN1GLAKMT2A
SCHEMBL6649153 0.88 AR (0.44) ARPGRLMNACYP2D6TSHR
SCHEMBL13893984 0.81 HTR2A (0.46) ARPGRHTR2AHTR2CCHRNB2
SCHEMBL6649781 0.81 AR (0.42) ARPGRMEN1KMT2AGAA
SCHEMBL6649479 0.78 MEN1 (0.41) ARPGRMEN1KMT2AHTR2A
SCHEMBL8140136 0.78 DRD2 (0.42) ARPGRDRD2DRD4ESR2
SCHEMBL6648615 0.76 BCHE (0.50) ARPGRHTR2CBCHE
SCHEMBL19909810 0.72 DRD2 (0.40) ARDRD2DRD4ESR2TMEM97
SCHEMBL29519369 0.72 DRD2 (0.40) ALDH1A1DRD2DRD4ESR2CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448405-B1 COUPLING A 2-HALO-5-NITROBENZOIC ACID AND A 2-METHOXYPHENYL BORONIC ACID; CYCLIZING TO A NITROBENZOCOUMARIN; REDUCING TO THE AMINE; CONVERTING TO A COUMARINO(3,4-F)QUINOLINE; REDUCTION TO A 5H-CHROMENO(3,4-F)QUINOLINE LIGAND PHARMACEUTICALS INCORPORATED 2002-09-10 US disclosed